DBV TECHNOLOGIES News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

31.08.21	DBV Technologies to Participate at Upcoming Investor Conferences (GlobeNewswire)
09.08.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2021 (GlobeNewswire)
06.08.21	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
02.08.21	DBV Technologies Reports Second Quarter 2021 Financial Results and Recent Business Developments (GlobeNewswire)
26.07.21	DBV Technologies to Report First Half 2021 Financial Results and Business Updates on August 2, 2021 (GlobeNewswire)
07.07.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2021 (GlobeNewswire)
15.06.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2021 (GlobeNewswire)
02.06.21	DBV Technologies to Present at Upcoming Investor Conferences (GlobeNewswire)
19.05.21	DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Appointment of Dr. Adora Ndu, Pharm.D., J.D., and Dr. Ravi Madduri Rao, M.D., Ph.D., as Members of its (GlobeNewswire)
17.05.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2021 (GlobeNewswire)
05.05.21	DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021 (GlobeNewswire)
03.05.21	DBV Technologies Reports Q1 2021 Financial Results (GlobeNewswire)
29.04.21	DBV Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
28.04.21	Monthly information regarding the total number of voting rights and total number of shares of the Company (GlobeNewswire)
28.04.21	Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed Virtual Session Due to COVID-19 Pandemic (GlobeNewswire)
02.04.21	DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors (GlobeNewswire)
02.04.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2021 (GlobeNewswire)
26.03.21	DBV Technologies Announces a New Chair of its Audit Committee and Date of its Annual General Meeting (GlobeNewswire)
17.03.21	DBV Technologies Announces Filing of 2020 Annual Report on Form 10-K and 2020 Universal Registration Document (GlobeNewswire)
12.03.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 28, 2021 (GlobeNewswire)
11.03.21	DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments (GlobeNewswire)
05.03.21	DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference (GlobeNewswire)
04.03.21	DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results (GlobeNewswire)
01.03.21	DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021 (GlobeNewswire)
24.02.21	DBV Technologies to Participate in Upcoming AAAAI 2021 Congress (GlobeNewswire)
22.02.21	DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer (GlobeNewswire)
19.02.21	DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference (GlobeNewswire)
11.02.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2021 (GlobeNewswire)
29.01.21	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
14.01.21	DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years (GlobeNewswire)
07.01.21	DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process (GlobeNewswire)
05.01.21	Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020 (GlobeNewswire)
15.12.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020 (GlobeNewswire)
24.11.20	DBV Technologies Announces Leadership Changes (GlobeNewswire)
11.11.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2020 (GlobeNewswire)
10.11.20	DBV Technologies to Highlight Data on Viaskin™ Peanut Treatment Delivery and Patient Experience at ACAAI 2020 (GlobeNewswire)
09.11.20	DBV Technologies to Participate in Upcoming Investor Conferences (GlobeNewswire)
02.11.20	DBV Technologies Announces Filing and Validation of Marketing Authorization Application for Viaskin™ Peanut by European Medicines Agency (GlobeNewswire)
30.10.20	DBV Technologies Reports September 30, 2020 Cash Position (GlobeNewswire)
08.10.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2020 (GlobeNewswire)
15.09.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of August 31, 2020 (GlobeNewswire)
09.09.20	DBV Technologies Announces Leadership Changes (GlobeNewswire)
02.09.20	DBV Technologies to Participate in Multiple September Investor Conferences (GlobeNewswire)
12.08.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2020 (GlobeNewswire)
04.08.20	DBV Technologies Receives Complete Response Letter from FDA for Viaskin Peanut BLA in Children Ages 4-11 Years (GlobeNewswire)
31.07.20	DBV Technologies Reports First Half 2020 Financial Results (GlobeNewswire)
20.07.20	Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF (GlobeNewswire)
15.07.20	Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2020 (GlobeNewswire)
10.07.20	DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Peanut in The Journal of Allergy and Clinical Immunology (GlobeNewswire)
26.06.20	DBV Technologies Provides Operational and Business Update (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	74.30	1.53 %	K V
Holcim	87.38	1.49 %	K V
Roche Hldg G	251.00	1.46 %	K V
Swiss Re	130.35	1.44 %	K V
UBS Group	27.07	1.35 %	K V
Swisscom	501.00	0.52 %	K V
Lonza Grp	532.40	0.26 %	K V
Nestle	74.08	0.14 %	K V
Sonova Hldg	295.60	0.00 %	K V
Geberit	512.20	-0.39 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu DBV TECHNOLOGIES

Aktien Top/Flop

Meistgelesene Nachrichten